<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article         dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>marmara med j</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Marmara Medical Journal</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1019-1941</issn>
                                        <issn pub-type="epub">1309-9469</issn>
                                                                                            <publisher>
                    <publisher-name>Marmara University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                                                                                                                                            <title-group>
                                                                                                                        <article-title>ACELLULAR PERTUSSIS VACCINES</article-title>
                                                                                                                                        </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Cebeci</surname>
                                    <given-names>Dilşad</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20161203">
                    <day>12</day>
                    <month>03</month>
                    <year>2016</year>
                </pub-date>
                                        <volume>14</volume>
                                        <issue>2</issue>
                                        <fpage>131</fpage>
                                        <lpage>133</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20160324">
                        <day>03</day>
                        <month>24</month>
                        <year>2016</year>
                    </date>
                                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1988, Marmara Medical Journal</copyright-statement>
                    <copyright-year>1988</copyright-year>
                    <copyright-holder>Marmara Medical Journal</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>Pertussis is a dangerous infectious disease that is well controlled world-wide by widespread immunization. The major cause of the decline in the morbidity and mortality of the disease is the intensive World Health Organization&#039;s Expanded Program on Immunization. However, pertussis still remains one of major diseases because of its high morbidity; an estimated 40 million pertussis cases occurred worldwide in 1994, resulting in 5 million episodes of pneumonia, 360000 deaths, and 50000 neurological complications (including permanent brain damage).</p></abstract>
                                                                                    
            
                                                                                
                                                                                                                                                    </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">/. Strebel PM, Guris D, Wassilak SGP. Pertussis. In: Maxcy-Rosenau-Last, eds. Public Health â Preventing Medicine. 14th ed. Connecticut: Appleton and Lange, 1998; 98-101.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Decker MD, Edwards KM. Acellular pertussis vaccines. Pediatr Cli north Am 2000; 42: 309- 335.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Cherry JD, Mortimer EA Jr, Hackell JG and the Multicenter Vaccine Study Groups: Clinical Trials in the United States and Japan with the Lederia-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines Dev Biol Stand I991;73:5I-??</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Gustafsson L, Hollander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five component acellular, and a whole cell pertussis vaccine. H Eng J Med 1996; 334: 349-355.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Greco D, Salmaso S, Mastranonio P, Gluliano M, Tozzi AE, Anemona A. A controlled trial of two acellular vaccines and one whole cell vaccine against pertussis. H Eng J Med 1996; 333: 1045-1050.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Schmitt HJ, Wirsing Von Konig CH, Heiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposre. JAMA 1996; 275: 37-41.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Decker MD, Edwards KM, Steinhoff MC, Rennels MB, Plchichero ME, Enflung JA. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995: 96 (Suppl): 557-566.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Taranger J, Trollfors B, Lagergard T. Mass vaccination with a monocomponent pertussis toxoid vaccine in a defined geographic area (abstract G-8). In Programs and Abstracts of the 37 th Interscience Conference of Antimicrobial Agents and Chemotherpy 1997, Toronto, Ontario, Canada.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Taranger J, Trollfors B, Lagergard T. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants. Pediatr Infect Dis J 1997; 16: 180-??</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">Ad hoc Group for the Study of Pertussis Vaccines: Placebo-controlled trial of two acellular pertussis vaccines in Sweden: Protective efficacy and adverse events. Lancet 1988; 1: 955-</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">Edwards KM, Decker MD, Barney S. Adult immunization with acellular pertussis vaccine JAMA 1993; 269: 53-56.</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 199; 28(Suppl 2): SI 18-23.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">Centers for Disease Control and Prevention: Diphteria, tetanus and pertussis: Recommended childhood immunization Schedule-United States. Recommendations for vaccine use and other preventive measures. Recommendations of the advisory committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep 1999; 48: 12s.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
